Comparative Pharmacology
Head-to-head clinical analysis: AMOXICILLIN versus PYOPEN.
Peer-Reviewed Evidence
Head-to-head clinical analysis: AMOXICILLIN versus PYOPEN.
AMOXICILLIN vs PYOPEN
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Amoxicillin is a beta-lactam antibiotic that inhibits bacterial cell wall synthesis by binding to penicillin-binding proteins (PBPs), inhibiting transpeptidase activity, and activating autolytic enzymes.
Carbenicillin is a bactericidal penicillin antibiotic that inhibits bacterial cell wall synthesis by binding to penicillin-binding proteins (PBPs), disrupting peptidoglycan cross-linking.
250-500 mg orally every 8 hours or 500-875 mg orally every 12 hours; for severe infections, up to 1 g orally every 8 hours.
4 g intravenously every 4 hours.
None Documented
None Documented
Terminal elimination half-life: 1-1.5 hours in normal renal function. Prolonged to 7-20 hours in end-stage renal disease.
Clinical Note
moderateAmoxicillin + Acemetacin
"Amoxicillin may decrease the excretion rate of Acemetacin which could result in a higher serum level."
Clinical Note
moderateAmoxicillin + Probenecid
"The serum concentration of Probenecid can be increased when it is combined with Amoxicillin."
Clinical Note
moderateAmoxicillin + Fluconazole
"The metabolism of Fluconazole can be decreased when combined with Amoxicillin."
Clinical Note
moderateAmoxicillin + Clotrimazole
30-60 minutes in normal renal function; prolonged to 2-4 hours in moderate renal impairment (CrCl 10-30 mL/min) and up to 10 hours in severe renal failure.
Renal: 60-80% unchanged via glomerular filtration and tubular secretion. Biliary: up to 20% excreted in bile. Fecal: minimal.
Primarily renal (60-90% unchanged via glomerular filtration and tubular secretion); small amounts biliary (10-30%) and fecal (<10%).
Category A/B
Category C
Penicillin Antibiotic
Penicillin Antibiotic
"The metabolism of Clotrimazole can be decreased when combined with Amoxicillin."